Inicio
Resultado de la búsqueda
1 búsqueda de la palabra clave 'autologous stem cell transplantation'
Clasificado(s) por (Año de edición descendente) Refinar búsqueda Genera el flujo rss de la búsqueda
Enlace permanente de la investigación
Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study / Kenny Mauricio Gálvez Cárdenas
Título : Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study Tipo de documento : documento electrónico Autores : Kenny Mauricio Gálvez Cárdenas, Fecha de publicación : 2020 Títulos uniformes : Leukemia and Lymphoma Idioma : Inglés (eng) Palabras clave : Multiple myeloma Latin America autologous stem cell transplantation proteasome inhibitor Resumen : The aim of this study was to describe clinical and survival characteristics of transplant-eligible multiple myeloma (MM) patients in Latin America (LA), with a special focus on differences between public and private healthcare facilities. We included 1293 patients diagnosed between 2010 and 2018. A great disparity in outcomes and survival between both groups was observed. Late diagnosis and low access to adequate frontline therapy and ASCT in public institutions probably explain these differences. Patients treated with novel drug induction protocols, followed by autologous stem cell transplantation (ASCT) and maintenance, have similar overall survival compared to that published internationally. Mención de responsabilidad : Camila Peña , Eloisa Riva , Natalia Schutz , Luz Tarín-Arzaga , Humberto Martínez-Cordero , Virginia Bove , Rocío Osorio , Mauricio Chandía , Cecilia Beltrán , Javier Schulz , Daniela Cardemil , Carolina Contreras , Carmen Gloria Vergara , Javiera Donoso , Marcela Espinoza , Gabriel La Rocca , Hernán López-Vidal , Pilar León , Christine Rojas Hopkins , Pablo Soto , Sandra Aranda , Vivianne Torres , Macarena Roa , Paola Ochoa , Patricio Jose Duarte , Guillermina Remaggi , Sebastián Yantorno , Ariel Corzo , Soledad Zabaljauregui , Claudia Shanley , Sergio Lopresti , Sergio Orlando , Verónica Verri , Luis Quiroga , Carlos García , Vanesa Fernández , Jhoanna Ramirez , Alicia Molina , María Pacheco , Alex Mite , Inés Reyes , Brenner Sabando , Francisca Ramírez , Claudia Sossa , Virginia Abello , Henry Idrobo , Kenny Mauricio Galvez Cardenas , Domingo Saavedra , Guillermo Quintero , Raimundo Gazitúa , Lina Gaviria , Rigoberto Gomez , Mónica Osuna , Alicia Henao-Uribe , Omar Cantú-Martínez , Referencia : Leuk Lymphoma. 2020 Dec;61(13):3112-3119. DOI (Digital Object Identifier) : 10.1080/10428194.2020.1804558 PMID : 32844699 En línea : https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1804558 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5127 Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study [documento electrónico] / Kenny Mauricio Gálvez Cárdenas, . - 2020.
Obra : Leukemia and Lymphoma
Idioma : Inglés (eng)
Palabras clave : Multiple myeloma Latin America autologous stem cell transplantation proteasome inhibitor Resumen : The aim of this study was to describe clinical and survival characteristics of transplant-eligible multiple myeloma (MM) patients in Latin America (LA), with a special focus on differences between public and private healthcare facilities. We included 1293 patients diagnosed between 2010 and 2018. A great disparity in outcomes and survival between both groups was observed. Late diagnosis and low access to adequate frontline therapy and ASCT in public institutions probably explain these differences. Patients treated with novel drug induction protocols, followed by autologous stem cell transplantation (ASCT) and maintenance, have similar overall survival compared to that published internationally. Mención de responsabilidad : Camila Peña , Eloisa Riva , Natalia Schutz , Luz Tarín-Arzaga , Humberto Martínez-Cordero , Virginia Bove , Rocío Osorio , Mauricio Chandía , Cecilia Beltrán , Javier Schulz , Daniela Cardemil , Carolina Contreras , Carmen Gloria Vergara , Javiera Donoso , Marcela Espinoza , Gabriel La Rocca , Hernán López-Vidal , Pilar León , Christine Rojas Hopkins , Pablo Soto , Sandra Aranda , Vivianne Torres , Macarena Roa , Paola Ochoa , Patricio Jose Duarte , Guillermina Remaggi , Sebastián Yantorno , Ariel Corzo , Soledad Zabaljauregui , Claudia Shanley , Sergio Lopresti , Sergio Orlando , Verónica Verri , Luis Quiroga , Carlos García , Vanesa Fernández , Jhoanna Ramirez , Alicia Molina , María Pacheco , Alex Mite , Inés Reyes , Brenner Sabando , Francisca Ramírez , Claudia Sossa , Virginia Abello , Henry Idrobo , Kenny Mauricio Galvez Cardenas , Domingo Saavedra , Guillermo Quintero , Raimundo Gazitúa , Lina Gaviria , Rigoberto Gomez , Mónica Osuna , Alicia Henao-Uribe , Omar Cantú-Martínez , Referencia : Leuk Lymphoma. 2020 Dec;61(13):3112-3119. DOI (Digital Object Identifier) : 10.1080/10428194.2020.1804558 PMID : 32844699 En línea : https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1804558 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5127 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001386 AC-2020-063 Archivo digital Producción Científica Artículos científicos Disponible